人工智能:病理学家的武器库中的一个新工具用于诊断IBD
Anna Lucia Cannarozzi1, Luca Massimino2, Anna Latiano1
1Division of Gastroenterology, Fondazione IRCCS - Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Computational and structural biotechnology journal
|September 30, 2024
概括
人工智能 (AI) 通过分析胃肠炎症组织病理学来帮助诊断炎症性肠病 (IBD). 人工智能为区分克罗恩病 (CD) 和性结肠炎 (UC) 与非IBD疾病提供了更高的准确性和速度.
科学领域:
- 胃肠病学 胃肠病学
- 病理学 病理学 病理学
- 人工智能的人工智能
背景情况:
- 炎症性肠病 (IBD),包括克罗恩病 (CD) 和性结肠炎 (UC),存在复杂的诊断挑战.
- 准确的IBD差异诊断依赖于多学科的方法,其中组织病理学起着至关重要的作用.
- 目前的组织病理学评估面临的局限性是由于采样变异性和主观的人类解释,可能导致诊断差异.
研究的目的:
- 审查人工智能 (AI) 诊断IBD的最新进展.
- 总结AI在IBD患者内镜活检的组织病理学分析中的应用.
- 讨论AI在胃肠道炎症的临床实践中的优点和局限性.
主要方法:
- 关于人工智能在IBD组织病理学中的应用现有文献的综述.
- 专注于人工智能技术,用于从内镜活检中自动分析医疗图像.
- 探索AI在区分IBD亚型和非IBD疾病中的作用.
主要成果:
- 人工智能展示了胃肠组织病理学自动分析的潜力,提供了更高的准确性,精度和速度.
- 新兴的人工智能技术在克服IBD诊断中主观人类判断的局限性方面显示出前景.
- 人工智能应用对胃肠道炎症的组织学分析越来越感兴趣.
结论:
- 人工智能提供了一种有价值的工具,可以在IBD的诊断中增强组织病理学分析.
- 人工智能可以提高区分UC,CD和非IBD结肠炎的准确性和效率.
- 需要进一步的研究和验证,才能将AI完全整合到IBD管理的日常临床实践中.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
323
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
323
01:30Inflammatory Bowel Disease II: Crohn's Disease
194
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
194
01:29Inflammatory Bowel Disease IV: Pharmacological Management
118
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
118
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
148
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
148
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117
01:21Inflammatory Bowel Disease V: Surgical Management
128
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
128